Abstract
Gender-medicine has been very successful in discovering gaps in medical knowledge, disclosing biases in earlier research, and generating new results. It has superseded a more androcentric and sexist medicine. Yet, its development should not be understood in terms of a further approximation of value-freedom. Rather, it is a case of better value-laden science due to an enhanced pluralism in medicine and society. This interpretation is based on an account of the origins of gender-medicine in the feminist women’s health movement and an analysis of the debate on inclusion of women in clinical trials. Consequently, the history of gender-medicine provides support for a procedural account of objectivity that stresses the importance of a diversity of perspectives.
Similar content being viewed by others
Notes
This is not to be read as a claim about the accuracy and completeness of Laqueur’s account. Historical conceptions of sex and gender might very well be more complex than his description suggests (cf., eg., Voss 2010). However, I want to employ his distinction in order to point out some important differences.
Heavy physical labour, for example in factories, was not quite as controversial (cf. Bullough and Voght 1973, 70 f).
With the development of psychoanalysis, hysteria later became a primarily psychological disease (though connected to the physiological problem of a lacking penis causing envy). In the latter twentieth century, hysteria lost its status as an official diagnosis due to its vague character as well as its pejorative connotation. It might be an interesting question for future research how much of hysteria has actually survived into concepts of PMS and PMDD (Premenstrual Dysphoric Disorder), which has been included as an official diagnosis in the DSM-5 (cf. American Psychiatric Association 2013).
Jeffcoate, Thomas (1967). Principles of Gynecology (3rd edition). London: Butterworth; quoted from Scully and Bart (1973), 1048.
Novak, Edmund; Jones, Georgeanna S.; Jones, Howard (1970). Novak’s Textbook of Gynecology. Baltimore: Williams & Wilkens; quoted from ibid.
Willson James R. et al. (1971). Obstetrics and Gynecology (4th edition). Saint Louis: Mosby; quoted from ibid.
Willson (1971); quoted from Weiss (1978), 217.
Willson (1971); quoted from ibid., 216.
At the time, it was, for instance, common practice for doctors and pharmacists to remove package inserts in order to avoid hysteric, hypochondriac reactions from women.
Oftentimes, complaints were not only not taken serious, but even interpreted in terms of a moral weakness of the female patients:
“an exaggeration of minor discomfort […] may even be an excuse to avoid doing something that is disliked” (Jeffcoate 1967, quoted from Lennane and Lennane 1973, 288);
„very little can be done for the patient who prefers to use menstrual symptoms as a monthly refuge from responsibility and effort“(Benson, Ralph C. 1972. Gynaecology and Obstetrics. In M. Krupp & M. Chatton (Eds.), Current Diagnosis and Treatment. Los Altos: Lange Medical Publications, 377–434; quoted from ibid., 289).
It is important to note that there are not only biological but also social factors relevant to CHD in men and women. An example of the latter is the difference in risks such as a low socioeconomic status (a more frequent problem in older women than in men).
A similar review of published clinical trials in the New England Journal of Medicine, 1994–1999, found an average rate of 24.6 % of female subjects, with only 14 % of the studies actually employing a gender-sensitive analysis of results (cf. Ramasubbu et al. 2001).
This is a recurrent conflict in medicine as an application-oriented science, which has to balance the needs of medical practice and of research, the latter being made much easier (or “purer”) by a reduction of possibly intervening factors that in turn creates problems of applicability.
As Epstein (2007) points out, the NIH’s reaction towards these criticisms in their interpretation of the guidelines has greatly facilitated their acceptance. For example, women need to be included only in Phase-III trials where no data support assumptions of a similarity of the sexes, won by studies on laboratory animals of both sexes. Another point is that the ratio of minorities does not have to be demographically representative or always of a sample size that allows for statistically significant inferences.
It might be countered that not all of these questions were epistemically relevant and therefore need not all be value-free (for instance, decisions on the choice of research projects). For an argument on why such aspects have an indirect impact on justification cf., e.g., Bueter (2015), Ohkrulik (1994), Elliott and McKaughan (2009).
There are of course numerous other accounts in social and feminist epistemology of relevance here; also, Longino’s approach is not without its problems. For reasons of space, I restrain myself here to proposing Longino’s notion of social objectivity as one helpful way to understand the development of gender-medicine. For a detailed discussion of Longino as well as other positions on the question of science and values cf. Bueter 2012.
References
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5 edition: DSM-5. APA, Washington, DC
Blake MB, Ince M, Dean CJ (2005) Inclusion of women in cardiac research: current trends and need for reassessment. Gend Med 2:71–75
Boston Women’s Health Book Collective (1973) Our bodies, ourselves. A book by and for women, 2nd rev. edn. Simon and Schuster, New York
Brawley OM (1995) Response to “Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993—the perspective of NIH clinical trialists”. Control Clin Trials 16:293–295
Bueter A (2012) Das Wertfreiheitsideal in der Sozialen Erkenntnistheorie: Objektivität. Pluralismus und das Beispiel Frauengesundheitsforschung, Ontos, Frankfurt
Bueter A (2015) The irreducibility of value-freedom to theory assessment. Stud Hist Philos Sci 49:18–26
Buist AS, Greenlick MR (1995) Response to “Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993—the perspective of NIH clinical trialists”. Control Clin Trials 16:296–298
Bullough V, Voght M (1973) Women, menstruation, and nineteeth-century medicine. Bull Hist Med 47:66–82
Clarke E (1873) Sex in education, or: a fair chance for girls. Wildside, Rockville 2007
Dreifus C (ed) (1978) Seizing our bodies: the politics of women’s health. Vintage Books, New York
Ehrenreich B, English D (1978a) For her own good: 150 years of the experts’ advice to women. Anchor Books, New York
Ehrenreich B, English D (1978b) Complaints and disorders: the sexual politics of sickness. In: Dreifus C (ed) Seizing our bodies: the politics of women’s health. Vintage Books, New York, pp 43–56
Ehrenreich,B (1975) Feminism and the cultural revolution in health. In: Proceedings for the 1975 conference on women and health, pp 11–13. http://web.archive.org/web/20110912153213/http://www.ourbodiesourselves.org/uploads/pdf/women-and-health.pdf. Cited 25 May 2015
Elliott KC and McKaughan DJ (2009) How values in discovery and pursuit alter theory appraisal. Philos Sci 76:598–611
Epstein S (2007) Inclusion: the politics of difference in medical research. University of Chicago Press, Chicago
Fausto-Sterling A (1985) Myths of gender: biological theories about women and men. Basic Books, New York
Fischer-Homberger E (1979) Krankheit Frau und andere Arbeiten zur Medizingeschichte der Frau. Hans Huber, Bern
Gurwitz JH, Col NF, Avorn J (1992) The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268:1417–1422
Healy B (1991) The Yentl-syndrome. N Engl J Med 325:274–275
Khaw K (1993) Where are the women in studies of coronary heart disease? White middle aged men are not necessarily representative of all humankind. Br Med J 306:1145–1147
King KM, Paul P (1996) A historical review of the depiction of women in cardiovascular literature. West J Nurs Res 18:89–102
Krieger N, Fee E (1996) Man-made medicine and women’s health: the biopolitics of sex/gender and race/ethnicity. In: Moss KL (ed) Man-made medicine: women’s health, public policy, and reform. Duke University Press, Durham, pp 15–35
Kushner R (1978) The politics of breast cancer. In: Dreifus C (ed) Seizing our bodies: the politics of women’s health. Vintage Books, New York, pp 186–194
Laqueur T (1990) Making sex: body and gender from the Greeks to Freud. Harvard University Press, Cambridge
Larned D (1978) The epidemic in unnecessary hysterectomy. In: Dreifus C (ed) Seizing our bodies: the politics of women’s health. Vintage Books, New York, pp 195–208
Lennane KJ, Lennane RJ (1973) Alleged psychogenic disorders in women—a possible manifestation of sexual prejudice. N Engl J Med 288:288–292
Longino HE (1990) Science as social knowledge: values and objectivity in scientific inquiry. Princeton University Press, Princeton
MacIntyre S, Hunt K, Sweeting H (1996) Gender differences in health: Are things really as simple as they seem? Soc Sci Med 42:617–624
Mann C (1995) Women’s health research blossoms. Science 269:766–770
Marieskind H (1975) The women’s health movement. Int J Health Serv 5:217–223
Marmot MG, Rose G, Shipley M et al (1978) Employment grade and coronary heart disease in British civil servants. J Epidemiol Commun H 32:244–249
Marmot MG, Stansfeld S, Patel C et al (1991) Health inequalities among British civil servants: the Whitehall II study. Lancet 337:1387–1393
Martin E (1987) The woman in the body: a cultural analysis of reproduction. Beacon Press, Boston
McCormick KM, Bunting SM (2002) Application of feminist theory in nursing research: the case of women and cardiovascular disease. Health Care Women Int 23:820–834
Meinert CL (1995a) Comments on NIH clinical trial valid analysis requirement. Control Clin Trials 16:304–306
Meinert CL (1995b) The inclusion of women in clinical trials. Science 269:795–796
Morgen S (2002) Into our own hands: the women’s health movement in the United States, 1969–1999. Rutgers University Press, New Brunswick
MRFIT Research Group (1982) Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 248:1465–1477
Ohkrulik K (1994) Gender and the biological sciences. In: Curd M, Cover JA (eds) Philosophy of science: the central issues. Norton, New York, pp 192–208
Ramasubbu K, Gurm H, Litaker D (2001) Gender bias in clinical trials: Do double standards still apply? J Women Health Gen-B 10:757–764
Riska E (2002) From type A man to hardy man: masculinity and health. Sociol Health Ill 24:347–358
Rosser S (1994) Women’s health—missing from U. S. medicine. Indiana University Press, Bloomington
Rosser S (2002) An overview of women’s health in the U.S. since the Mid-1960s. Hist Technol 18:355–369
Ruzek SB (1978) The women’s health movement: feminist alternatives to medical control. Praeger, New York
Schiebinger L (1999) Has feminism changed science?. Harvard University Press, Cambridge
Scully D, Bart P (1973) A funny thing happened on the way to the orifice: women in gynecology textbooks. Am J Sociol 78:1045–1050
Seaman B (1969) The doctors’ case against the pill, rev edn. Hunterhouses, Alameda
Steering Committee of the Physicians’ Health Study Research Group (1989) Final report of the aspirin component of the ongoing Physician’s Health Study. N Engl J Med 321:129–135
Tuana N (1993) The less noble sex: scientific, religious, and philosophical conceptions of woman’s nature. Indiana University Press, Bloomington
Voss H (2010) Making sex revisited. Dekonstruktion des Geschlechts aus biologisch-medizinischer Perspektive, Transcript, Bielefeld
Weber T, Auer J, Berent R et al (2008) Kardiologie. In: Rieder A, Lohff B (eds) Gender Medizin: Geschlechtsspezifische Aspekte für die Klinische Praxis, 2nd edn. Springer, Wien, pp 343–387
Weiss K (1975) Vaginal cancer: An iatrogenic disease? Int J Health Care 5:235–251
Weiss K (1978) What medical students learn about women. In: Dreifus C (ed) Seizing our bodies: the politics of women’s health. Vintage Books, New York, pp 212–222
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bueter, A. Androcentrism, Feminism, and Pluralism in Medicine. Topoi 36, 521–530 (2017). https://doi.org/10.1007/s11245-015-9339-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11245-015-9339-y